Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Cyclopentolate products are in shortage in Canada (1 of 4 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Eye drops used to dilate the pupil for eye examinations.
Products affected
1 / 4
In shortage since
Apr 15, 2016
Reports on file
14
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ODAN-CYCLOPENTOLATE
0.5% · SOLUTION · ODAN LABORATORIES LTD
DIN 00626635 · since Apr 15, 2016, no end estimate · Disruption of the manufacture of the drug.
Resolved
CYCLOGYL
1% · DROPS · ALCON CANADA INC
DIN 00252506 · ended Sep 30, 2024 · Requirements related to complying with good manufacturing practices.
Resolved
ODAN-CYCLOPENTOLATE
1% · SOLUTION · ODAN LABORATORIES LTD
DIN 00626627 · ended May 24, 2024 · Change in manufacturing site
Resolved
ODAN-CYCLOPENTOLATE
1% · SOLUTION · ODAN LABORATORIES LTD
DIN 00626627 · ended Oct 4, 2023 · Demand increase for the drug.
Resolved
ODAN-CYCLOPENTOLATE
1% · SOLUTION · ODAN LABORATORIES LTD
DIN 00626627 · ended Aug 4, 2023 · Demand increase for the drug.
Resolved
MINIMS CYCLOPENTOLATE HYDROCHLORIDE
1% · SOLUTION
DROPS · BAUSCH HEALTH, CANADA INC.
DIN 02148382 · ended Jan 23, 2023 · Delay in shipping of the drug.
Resolved
MINIMS CYCLOPENTOLATE HYDROCHLORIDE
1% · SOLUTION
DROPS · BAUSCH HEALTH, CANADA INC.
DIN 02148382 · ended Jun 8, 2022 · packaging issue
Resolved
ODAN-CYCLOPENTOLATE
1% · SOLUTION · ODAN LABORATORIES LTD
DIN 00626627 · ended May 11, 2021 · Disruption of the manufacture of the drug.
Showing 12 of 14 reports. All reports are on file with Health Canada.
What's happening
Cyclopentolate is currently affected by an active shortage report filed with Health Canada by ODAN LABORATORIES LTD.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Cyclopentolate is classified under “MYDRIATICSAND CYCLOPLEGICS” (ATC S01FA).
Recent changes
No changes recorded yet.
Common questions
What is Cyclopentolate used for?
Eye drops used to dilate the pupil for eye examinations.
When will Cyclopentolate be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Cyclopentolate in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.